|
Griffiths, Elizabeth A; Srivastava, Pragya; Matsuzaki, Junko et al. (2018) NY-ESO-1 Vaccination in Combination with Decitabine Induces Antigen-Specific T-lymphocyte Responses in Patients with Myelodysplastic Syndrome. Clin Cancer Res 24:1019-1029
|
|
Long, Mark D; Smiraglia, Dominic J; Campbell, Moray J (2017) The Genomic Impact of DNA CpG Methylation on Gene Expression; Relationships in Prostate Cancer. Biomolecules 7:
|
|
Singh, Prashant K; van den Berg, Patrick R; Long, Mark D et al. (2017) Integration of VDR genome wide binding and GWAS genetic variation data reveals co-occurrence of VDR and NF-?B binding that is linked to immune phenotypes. BMC Genomics 18:132
|
|
Long, Mark D; Campbell, Moray J (2017) Integrative genomic approaches to dissect clinically-significant relationships between the VDR cistrome and gene expression in primary colon cancer. J Steroid Biochem Mol Biol 173:130-138
|
|
Mu, Ping; Zhang, Zeda; Benelli, Matteo et al. (2017) SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer. Science 355:84-88
|
|
Srivastava, Pragya; Paluch, Benjamin E; Matsuzaki, Junko et al. (2016) Induction of cancer testis antigen expression in circulating acute myeloid leukemia blasts following hypomethylating agent monotherapy. Oncotarget 7:12840-56
|
|
Swetzig, Wendy M; Wang, Jianmin; Das, Gokul M (2016) Estrogen receptor alpha (ER?/ESR1) mediates the p53-independent overexpression of MDM4/MDMX and MDM2 in human breast cancer. Oncotarget 7:16049-69
|
|
Paluch, Benjamin E; Naqash, Abdul R; Brumberger, Zachary et al. (2016) Epigenetics: A primer for clinicians. Blood Rev 30:285-95
|
|
Verone-Boyle, Alissa R; Shoemaker, Suzanne; Attwood, Kristopher et al. (2016) Diet-derived 25-hydroxyvitamin D3 activates vitamin D receptor target gene expression and suppresses EGFR mutant non-small cell lung cancer growth in vitro and in vivo. Oncotarget 7:995-1013
|
|
Marlowe, Timothy A; Lenzo, Felicia L; Figel, Sheila A et al. (2016) Oncogenic Receptor Tyrosine Kinases Directly Phosphorylate Focal Adhesion Kinase (FAK) as a Resistance Mechanism to FAK-Kinase Inhibitors. Mol Cancer Ther 15:3028-3039
|
Showing the most recent 10 out of 54 publications
